These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 7910323)
1. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Kedar RP; Bourne TH; Powles TJ; Collins WP; Ashley SE; Cosgrove DO; Campbell S Lancet; 1994 May; 343(8909):1318-21. PubMed ID: 7910323 [TBL] [Abstract][Full Text] [Related]
2. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy]. Hauth E; Libera H; Kimmig R; Forsting M Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840 [TBL] [Abstract][Full Text] [Related]
3. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study. Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921 [TBL] [Abstract][Full Text] [Related]
4. Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring. Vosse M; Renard F; Coibion M; Neven P; Nogaret JM; Hertens D Eur J Obstet Gynecol Reprod Biol; 2002 Feb; 101(1):58-63. PubMed ID: 11803101 [TBL] [Abstract][Full Text] [Related]
5. Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen. Lee M; Piao J; Jeon MJ Yonsei Med J; 2020 Apr; 61(4):317-322. PubMed ID: 32233174 [TBL] [Abstract][Full Text] [Related]
6. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Lahti E; Blanco G; Kauppila A; Apaja-Sarkkinen M; Taskinen PJ; Laatikainen T Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):660-4. PubMed ID: 8469450 [TBL] [Abstract][Full Text] [Related]
7. Hysteroscopically targeted biopsies compared with blind samplings in endometrial assessment of menopausal women taking tamoxifen for breast cancer. Garuti G; Cellani F; Colonnelli M; Garzia D; Gonfiantini C; Luerti M J Am Assoc Gynecol Laparosc; 2004 Feb; 11(1):62-7. PubMed ID: 15104834 [TBL] [Abstract][Full Text] [Related]
8. Sonohysterography compared with endometrial biopsy for evaluation of the endometrium in tamoxifen-treated women. Hann LE; Kim CM; Gonen M; Barakat R; Choi PH; Bach AM J Ultrasound Med; 2003 Nov; 22(11):1173-9. PubMed ID: 14620887 [TBL] [Abstract][Full Text] [Related]
9. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Chin J; Konje JC; Hickey M Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400 [TBL] [Abstract][Full Text] [Related]
10. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586 [TBL] [Abstract][Full Text] [Related]
11. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients. Cheng WF; Lin HH; Torng PL; Huang SC Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568 [TBL] [Abstract][Full Text] [Related]
13. [Tamoxifen and endometrial pathology]. Negoiţă M; Terinte C; Mihailovici MS Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468 [TBL] [Abstract][Full Text] [Related]
14. The effect of tamoxifen on the endometrium, serum lipids and hypothalamus pituitary axis in the postmenopausal breast cancer patients. Kavak ZN; Binöz S; Ceyhan N; Pekin S Acta Obstet Gynecol Scand; 2000 Jul; 79(7):604-7. PubMed ID: 10929963 [TBL] [Abstract][Full Text] [Related]
15. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings. Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510 [TBL] [Abstract][Full Text] [Related]
16. The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo. Powles TJ; Bourne T; Athanasiou S; Chang J; Gruböck K; Ashley S; Oakes L; Tidy A; Davey J; Viggers J; Humphries S; Collins W Br J Cancer; 1998 Jul; 78(2):272-5. PubMed ID: 9683306 [TBL] [Abstract][Full Text] [Related]
17. Factors associated with endometrial pathology during tamoxifen therapy in women with breast cancer: a retrospective analysis of 821 biopsies. Jeon J; Kim SE; Lee DY; Choi D Breast Cancer Res Treat; 2020 Jan; 179(1):125-130. PubMed ID: 31541382 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation of endometrium during tamoxifen therapy of breast cancer]. Obrebowska A; Sibila-Owczarska A; Sajdak S Ginekol Pol; 2002 Nov; 73(11):1109-12. PubMed ID: 12722407 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of endometrial proliferation in pipelle biopsies in tamoxifen-treated postmenopausal women with breast cancer in Kuwait. Al-Azemi M; Labib NS; Motawy MM; Temmim L; Moussa MA; Omu AE Med Princ Pract; 2004; 13(1):30-4. PubMed ID: 14657616 [TBL] [Abstract][Full Text] [Related]
20. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study. Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]